ADHD drugs continue to show benefit in trials.(Lisdexamfetamine from Shire Pharmaceuticals Group PLC treats attention deficit hyperactivity … An article from: Family Practice News

Product Description
This digital document is an article from Family Practice News, published by Thomson Gale on August 1, 2007. The length of the article is 606 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: ADHD drugs continue to show benefit in trials.(Mental Health)(Lisdexamfetamine from Shire Pharmaceuticals Group PLC treats attention deficit hyperactivity disorder)
Author: Timothy F. Kirn
Publication: Family Practice News (Magazine/Journal)
Date: August 1, 2007
Publisher: Thomson Gale
Volume: 37 Issue: 15 Page: 24(1)

Distributed by Thomson Gale
ADHD drugs continue to show benefit in trials.(Lisdexamfetamine from Shire Pharmaceuticals Group PLC treats attention deficit hyperactivity … An article from: Family Practice News